In silico insights on Disialoganglioside GD2 : A Potential target for Pediatric Neuroblastoma.
CONCLUSION: Conclusively, the virtual screened drug is better inhibitor than the established drug and can be further subjected for wet lab studies.
PMID: 31721713 [PubMed - as supplied by publisher]
Source: Current Topics in Medicinal Chemistry - Category: Chemistry Authors: Limaye A, Sweta J, Mudgal U, Mukherjee S, Sharma S, Hussain T, Nayarisseri A, Singh SK Tags: Curr Top Med Chem Source Type: research
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Chemistry | Genetics | Molecular Biology | Neuroblastoma | Neurology | Pediatrics | Study | Toxicology